HTB

COVID-19 vaccine study opens for recruitment in UK

Simon Collins, HIV i-Base

Researchers at University of Oxford working on a preventative COVID-19 vaccine have started screening healthy volunteers (aged 18-55). [1, 2]

This is for an upcoming ChAdOx1 nCoV-19 vaccine trial in the Thames Valley Region. The vaccine based on an adenovirus vaccine vector and the SARS-CoV-2 spike protein is already in production but will not be available for several weeks.

The study will enrol 510 participants who will receive the vaccine or a placebo.

References

  1. Oxford COVID-19 vaccine programme opens for clinical trial recruitment. (27 March 2020).
    http://www.ox.ac.uk/news/2020-03-27-oxford-covid-19-vaccine-programme-opens-clinical-trial-recruitment#
  2. Lane R. Sarah Gilbert: carving a path towards a COVID-19 vaccine. The Lancet. doi: 10.1016/S0140-6736(20)30796-0 (2020).
    https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30796-0/fulltext

Links to other websites are current at date of posting but not maintained.